Tissue Sealants Market Analysis | India | 2016-2022 | MedCore

Tissue Sealants Market Analysis | India | 2016-2022 | MedCore

0

Tissue sealants and glues are used in surgical procedures and for some types of bleeding to seal the edges of tissue together, prevent leakage of fluid around the surgical sites and in some cases also to reduce adhesions. Thus, even though some products are indicated only for tissue sealing, they are also used
off-label as a hemostat and as an anti-adhesive as well. Broadly, tissue sealants can be classified into natural sealants and synthetic sealants. Natural sealants can further be segmented into fibrin and protein sealants.

  • Year: 2016
  • Scope: 2012-2022
  • Region: India
  • Published Date: 5/1/2016
  • Pages: 31
  • Type: MedCore

Fibrin sealants are blood-derived products that are absorbable and form fibrin clots to arrest bleeding during surgeries. Fibrin clots are formed when thrombin activates fibrinogen in the presence of certain clotting factors. Fibrin sealants should only be applied on dry surfaces and on oozing wounds. Profusely bleeding wounds would be too moist to establish a good seal. Fibrin sealants are used in a wide range of procedures including cardiac, vascular, lung, liver, reconstructive plastic, oral and maxillofacial surgery. More urologic and renal applications are also being reported. Thrombin and fibrinogen are either taken from the patient’s own blood (autologous) or from a pool of human donors (homologous). For the purpose of this research report, fibrin sealants in this section only refer to the liquid fibrin products and not the fibrin patches. The fibrin patches are considered under the combination hemostats category, due to the stark difference between the liquids and patches in terms of price, efficacy, ease of use, complexity in product preparation and other characteristics. 3.1.2 Protein-Based Sealants Protein-based sealants are generally used to seal large vessels and in anastomoses. They can be used as an adjunct to sutures and staples and have a tensile strength that is up to five times stronger than a bond made from fibrin sealants. Containing purified bovine serum albumin (BSA) and glutaraldehyde, these sealants are dispensed from a double barreled syringe. The two components mix at the tip of the syringe and are covalently bonded to each other to form a strong seal, independent of the body’s clotting cascade. The seal polymerizes in 30 seconds and reaches its bonding strength in 2 minutes. 3.1.3 Synthetic Tissue Sealants Polyethylene glycol (PEG) can be combined with synthetic peptides and protein polymers to form synthetic tissue sealants. When the monomers link, they form a bond or seal that can be used to prevent leakage of fluids, gases or solids. New synthetic tissue sealants consisting of a blend of two monomers, 2-octyl cyanoacrylate (2-OCA) and butyl lactoyl cyanoacytate (BLCA) have recently entered the market. Synthetic tissue sealants are ideal for vascular, pulmonary and gastrointestinal surgeries. Free of protein, human products and animal products, synthetic sealants pose no risk of transmitting disease, developing antibody resistance or causing infection.



The "Indian Market Report Suite for Wound and Tissue Management 2016 - MedCore" includes analysis on the following companies currently active in this market:
3M
Adeshwar Meditex Pvt Ltd
Aegis Lifesciences
Amla Mediquip
Angoor
Aristopharma
Atmos
B.Braun
Baxter
Beiersdorf India Pvt Ltd.
Biocer
Bipson Surgical Private Ltd
BSN Medical
Centennial Surgical Sutures Ltd
Chaitanya Orthopaedics
Coloplast
Convatec
Covidien
Datt Mediproducts Limited
Disha Surgicals Pvt Ltd.
Dr.Reddy Labs
Dyna Ortho
Dynamic Techno Medicals
Enterprises Pvt Ltd
EU Care India
Flamingo
For You NPWT
Futura Surgicare
Genzyme
Goldwin Medicare Ltd.
Hartmann
Hemcon Medical Technologies
HLL Lifecare Limited
Innocoll
JCB
Johnson & Johnson
JSB
Kinetic Concepts Inc.
Komal Health Care Pvt. Ltd
Lifesciences
Lohmann & Rauscher
Lotus Surgical
Medela
Meril MIL Laboratories Pvt. Ltd
Mölnlycke Health Care
Panther Health Care
Reach Surgical
Reliance Life Sciences
Smith & Nephew
Smith&Nephew
Stryker
Surgiwear
Sutures India Pvt Ltd
Tissuemed
Triage Meditech
Tynor India
Vissco

*Not all companies are currently active in every segment or sub-report from this suite. For more details contact an iData Research Product Advisor.




iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology


close-link
close-link

Subscribe to MedTech Market News - Get exclusive analyst articles, monthly newsletters and iData offers

close-link
close-link
close-link